Cite
APA Citation
Ngamphaiboon, N., Tanaka, K., Hong, R., Wan Ishak, W. Z., Yen, C., Sriuranpong, V., Takahashi, S., Srimuninnimit, V., Yeh, S., Oridate, N., Yang, M., Nohata, N., Koh, Y., Roy, A., Gumuscu, B., Swaby, R., & Tahara, M. (n.d.). 286OPhase III KEYNOTE-048 study of first-line pembrolizumab for recurrent/metastatic head and neck squamous cell carcinoma: Asia vs non-Asia subgroup analysis. Annals of oncology, 30, . http://access.bl.uk/ark:/81055/vdc_100098037804.0x000039